|
Name |
Phomopsichalasin G
|
Molecular Formula | C28H37NO4 | |
IUPAC Name* |
(1S,2S,3E,5R,7R,9E,11S,12R,14R,15S,16R)-2,12-dihydroxy-16-[(2-hydroxyphenyl)methyl]-5,7,14-trimethyl-13-methylidene-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-18-one
|
|
SMILES |
C[C@@H]1C/C=C/[C@@H]2[C@H](C(=C)[C@@H]([C@H]3[C@]2([C@H](/C=C/[C@@H](C1)C)O)C(=O)N[C@@H]3CC4=CC=CC=C4O)C)O
|
|
InChI |
InChI=1S/C28H37NO4/c1-16-8-7-10-21-26(32)19(4)18(3)25-22(15-20-9-5-6-11-23(20)30)29-27(33)28(21,25)24(31)13-12-17(2)14-16/h5-7,9-13,16-18,21-22,24-26,30-32H,4,8,14-15H2,1-3H3,(H,29,33)/b10-7+,13-12+/t16-,17+,18+,21-,22-,24+,25-,26+,28+/m1/s1
|
|
InChIKey |
GPYFHLIYZCGNSD-YJZFUNBLSA-N
|
|
Synonyms |
Phomopsichalasin G
|
|
CAS | NA | |
PubChem CID | 139586986 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 451.6 | ALogp: | 3.9 |
HBD: | 4 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 89.8 | Aromatic Rings: | 4 |
Heavy Atoms: | 33 | QED Weighted: | 0.501 |
Caco-2 Permeability: | -5.361 | MDCK Permeability: | 0.00000734 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.076 |
Human Intestinal Absorption (HIA): | 0.622 | 20% Bioavailability (F20%): | 0.806 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.179 | Plasma Protein Binding (PPB): | 87.34% |
Volume Distribution (VD): | 1.227 | Fu: | 2.66% |
CYP1A2-inhibitor: | 0.214 | CYP1A2-substrate: | 0.099 |
CYP2C19-inhibitor: | 0.456 | CYP2C19-substrate: | 0.494 |
CYP2C9-inhibitor: | 0.776 | CYP2C9-substrate: | 0.536 |
CYP2D6-inhibitor: | 0.222 | CYP2D6-substrate: | 0.408 |
CYP3A4-inhibitor: | 0.91 | CYP3A4-substrate: | 0.179 |
Clearance (CL): | 3.759 | Half-life (T1/2): | 0.232 |
hERG Blockers: | 0.173 | Human Hepatotoxicity (H-HT): | 0.762 |
Drug-inuced Liver Injury (DILI): | 0.626 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.931 | Maximum Recommended Daily Dose: | 0.969 |
Skin Sensitization: | 0.451 | Carcinogencity: | 0.118 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.972 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006133 | 0.818 | D06CWH | 0.226 | ||||
ENC004118 | 0.802 | D0S0LZ | 0.215 | ||||
ENC004119 | 0.784 | D01XDL | 0.212 | ||||
ENC004120 | 0.710 | D0WE3O | 0.208 | ||||
ENC004369 | 0.670 | D06BQU | 0.207 | ||||
ENC004370 | 0.655 | D05VQI | 0.207 | ||||
ENC004243 | 0.655 | D0Z9NZ | 0.204 | ||||
ENC003955 | 0.636 | D0L3MP | 0.201 | ||||
ENC004544 | 0.623 | D0Y0JH | 0.200 | ||||
ENC004918 | 0.623 | D0H1AR | 0.199 |